← Leaderboards
Michael J. Detmar
Massachusetts General Hospital
$3,440,302
Attributed
$3,440,302
Total exposure
5
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $150.3K · FY2006–10$200K$150K$100K$50K$0
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$3,440,302 · 5
By mechanism
R01$3,430,302 · 3
R13$10,000 · 1
P01$0 · 1
Top collaborators
No co-investigators on record.
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Timothy P Padera$10,637,651
- Rakesh K. Jain$48,476,214
- Eng H. Lo$32,456,318
- Kazuhide Hayakawa$6,403,808
- Hai Ning Shi$4,015,284
Others in their field
Top investigators on “Angiogenesis”
- David Heimbrook · Leidos Biomedical Research, Inc.$75,067,502
- Steven Terry Rosen · Beckman Research Institute/City Of Hope$59,567,306
- Martin Friedlander · Scripps Research Institute$48,350,175
- Larry Arthur$33,866,306
- Michael Simons · Yale University$30,647,106
- Henry Shelton Earp · Univ Of North Carolina Chapel Hill$29,372,588
Research focus
AngiogenesisVascular Endothelial Growth FactorsSquamous Cell CarcinomaGenetically Modified AnimalsSkin CirculationLaboratory MouseSkin NeoplasmsInflammationChemical CarcinogenesisSkinHuman TissueGene ExpressionWound HealingDimethylbenzanthraceneNeoplastic GrowthGreen Fluorescent ProteinsPhorbolsTissue /Cell CultureHypersensitivityCell LineNeoplastic ProcessAngiogenesis InhibitorsGene MutationThrombospondins
Grant awards (17)
2010 Molecular Mechanisms in Lymphatic Function and Disease Gordon Research Confe$10,000
R13 · FY2010 · HL · contact PI
VPF/VEGF in normal and neoplastic skin angiogenesis$145,925
R01 · FY2008 · CA · contact PI
VPF/VEGF in normal and neoplastic skin angiogenesis$145,925
R01 · FY2007 · CA · contact PI
VPF/VEGF in normal and neoplastic skin angiogenesis$150,283
R01 · FY2006 · CA · contact PI
THROMBOSPONDIN 1 IN PATHOLOGICAL SKIN ANGIOGENESIS$319,912
R01 · FY2004 · CA
VPF/VEGF in normal and neoplastic skin angiogenesis$241,214
R01 · FY2004 · CA
VPF/VEGF in normal and neoplastic skin angiogenesis$153,900
R01 · FY2004 · CA
THROMBOSPONDIN 1 IN PATHOLOGICAL SKIN ANGIOGENESIS$312,731
R01 · FY2003 · CA
VPF/VEGF IN NORMAL AND NEOPLASTIC SKIN ANGIOGENESIS$203,134
R01 · FY2003 · CA
THROMBOSPONDIN 1 IN PATHOLOGICAL SKIN ANGIOGENESIS$304,571
R01 · FY2002 · CA
VPF/VEGF IN NORMAL AND NEOPLASTIC SKIN ANGIOGENESIS$197,218
R01 · FY2002 · CA
The Role of PlGF in Normal and Neoplastic Angiogenesis$0
P01 · FY2002 · CA
THROMBOSPONDIN 1 IN PATHOLOGICAL SKIN ANGIOGENESIS$295,698
R01 · FY2001 · CA
Placental growth factor in skin angiogenesis$279,440
R01 · FY2001 · CA
VPF/VEGF IN NORMAL AND NEOPLASTIC SKIN ANGIOGENESIS$191,474
R01 · FY2001 · CA
THROMBOSPONDIN 1 IN PATHOLOGICAL SKIN ANGIOGENESIS$302,981
R01 · FY2000 · CA
VPF/VEGF IN NORMAL AND NEOPLASTIC SKIN ANGIOGENESIS$185,896
R01 · FY2000 · CA